News

This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...

For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.

Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...

Pronatalism is an old idea with roots in eugenics and nationalism, that is now fashionable among far-right influencers and policymakers. They talk...

This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Jessica Cussins, The Pharmaceutical Journal | 01.15.2015

In late 2014, the Google-backed company 23andMe announced that it would start selling its direct-to-consumer (DTC) genetic test in Canada and the...

By Caroline Humer and Christina Farr, Reuters | 01.15.2015

(Reuters) - Silicon Valley-based genetic testing company 23andMe is looking for new growth of its direct-to-consumer DNA tests abroad, building...

By John Drzik, CNBC | 01.15.2015

Innovation is vital to progress. Advances in science, have propelled economic and societal development throughout history. Today's emerging technologies have...

By Raksha Kumar, AlJazeera America | 01.14.2015
Untitled Document

Divya is 28, in her seventh month of pregnancy and a surrogate for an Australian couple in their...

By AP, Associated Press | 01.14.2015

The surrogate mothers of 13 babies fathered by a Japanese businessman are suing Thai authorities and seeking to regain custody...

By Steve Connor, The Independent [UK] | 01.14.2015
Untitled Document

The Government’s attempt to legalise so-called “three parent” babies is open to challenge by judicial review because of...

By John Lauerman and Makiko Kitamura, Bloomberg | 01.14.2015
Untitled Document

In three recent deals, drugmakers are betting that personal genetic maps will finally fulfill their early promise to...

By John Lauerman and Makiko Kitamura, Bloomberg | 01.14.2015
Untitled Document

In three recent deals, drugmakers are betting that personal genetic maps will finally fulfill their early promise to...